Literature DB >> 11907206

Rapid construction of adenoviral vectors by lambda phage genetics.

Duncan McVey1, Mohammed Zuber, Damodar Ettyreddy, Douglas E Brough, Imre Kovesdi.   

Abstract

Continued improvements of adenoviral vectors require the investigation of novel genome configurations. Since adenovirus can be generated directly by transfecting packaging cell lines with viral genomes isolated from plasmid DNA, it is possible to separate genome construction from virus production. In this way failure to generate a virus is not associated with an inability to generate the desired genome. We have developed a novel lambda-based system that allows rapid modification of the viral genome by double homologous recombination in Escherichia coli. The recombination reaction and newly generated genome may reside in a recombination-deficient bacterial host for enhanced plasmid stability. Furthermore, the process is independent of any restriction endonucleases. The strategy relies on four main steps: (i) homologous recombination between an adenovirus cosmid and a donor plasmid (the donor plasmid carries the desired modification[s] and flanking regions of homology to direct its recombination into the viral genome); (ii) in vivo packaging of the recombinant adenoviral cosmids during a productive lambda infection; (iii) transducing a recombination-deficient E. coli lambda lysogen with the generated lysate (the lysogen inhibits the helper phage used to package the recombinant andenoviral cosmid from productively infecting and destroying the host bacteria); (iv) effectively selecting for the desired double-recombinant cosmid. Approximately 10,000 double-recombinant cosmids are recovered per reaction with essentially all of them being the correct double-recombinant molecule. This system was used to generate quickly and efficiently adenoviral genomes deficient in the E1/E3 and E1/E3/E4 regions. The basis of this technology allows any region of the viral genome to be readily modified for investigation of novel configurations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907206      PMCID: PMC136085          DOI: 10.1128/jvi.76.8.3670-3677.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

2.  Packaging of the bacteriophage lambda chromosome: dependence of cos cleavage on chromosome length.

Authors:  M Feiss; D A Siegele
Journal:  Virology       Date:  1979-01-15       Impact factor: 3.616

3.  Packaging of the bacteriophage lambda chromosome: effect of chromosome length.

Authors:  M Feiss; R A Fisher; M A Crayton; C Egner
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

4.  Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying mutations near the right end of the viral genome.

Authors:  S S Challberg; G Ketner
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

5.  Isolation of type 5 adenovirus mutants with a cold-sensitive host range phenotype: genetic evidence of an adenovirus transformation maintenance function.

Authors:  Y S Ho; R Galos; J Williams
Journal:  Virology       Date:  1982-10-15       Impact factor: 3.616

6.  The infectivity of adenovirus genomes lacking DNA sequences from their left-hand termini.

Authors:  N D Stow
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

7.  An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

Authors:  A J Bett; W Haddara; L Prevec; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  The tac promoter: a functional hybrid derived from the trp and lac promoters.

Authors:  H A de Boer; L J Comstock; M Vasser
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis.

Authors:  N D Stow
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  9 in total

1.  Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

Authors:  Franck Lemiale; Hedi Haddada; Gary J Nabel; Douglas E Brough; C Richter King; Jason G D Gall
Journal:  Vaccine       Date:  2006-11-28       Impact factor: 3.641

Review 2.  Getting genetic access to natural adenovirus genomes to explore vector diversity.

Authors:  Wenli Zhang; Anja Ehrhardt
Journal:  Virus Genes       Date:  2017-07-15       Impact factor: 2.332

3.  Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.

Authors:  Zsolt Ruzsics; Markus Wagner; Andrea Osterlehner; Jonathan Cook; Ulrich Koszinowski; Hans-Gerhard Burgert
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.

Authors:  Sita Awasthi; Gregory G Mahairas; Carolyn E Shaw; Meei-Li Huang; David M Koelle; Christine Posavad; Lawrence Corey; Harvey M Friedman
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

5.  Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28.

Authors:  Christoph A Kahl; Jessica Bonnell; Suja Hiriyanna; Megan Fultz; Cassandra Nyberg-Hoffman; Ping Chen; C Richter King; Jason G D Gall
Journal:  Vaccine       Date:  2010-06-29       Impact factor: 3.641

6.  Characterization of human adenovirus 35 and derivation of complex vectors.

Authors:  Duncan McVey; Mohammed Zuber; Damodar Ettyreddy; Christopher D Reiter; Douglas E Brough; Gary J Nabel; C Richter King; Jason G D Gall
Journal:  Virol J       Date:  2010-10-19       Impact factor: 4.099

7.  Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response.

Authors:  Randall S MacGill; Thomas A Davis; Jennifer Macko; Helena J Mauceri; Ralph R Weichselbaum; C Richter King
Journal:  Clin Exp Metastasis       Date:  2007-07-25       Impact factor: 5.150

8.  Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.

Authors:  Jason G D Gall; Alena Lizonova; Damodar EttyReddy; Duncan McVey; Mohammed Zuber; Imre Kovesdi; Barbara Aughtman; C Richter King; Douglas E Brough
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

9.  Gene transfer into neural cells in vitro using adenoviral vectors.

Authors:  Thomas Southgate; Kurt M Kroeger; Chunyan Liu; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Protoc Neurosci       Date:  2008-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.